Cargando…
25-hydroxyvitamin D(3) generates immunomodulatory plasticity in human periodontal ligament-derived mesenchymal stromal cells that is inflammatory context-dependent
INTRODUCTION: Human periodontal ligament-derived mesenchymal stromal cells (hPDL-MSCs) exhibit a tight bi-directional interaction with CD4(+) T lymphocytes. The hPDL-MSCs’ immunomodulatory abilities are drastically enhanced by pro-inflammatory cytokines via boosting the expression of various immunom...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902380/ https://www.ncbi.nlm.nih.gov/pubmed/36761739 http://dx.doi.org/10.3389/fimmu.2023.1100041 |
Sumario: | INTRODUCTION: Human periodontal ligament-derived mesenchymal stromal cells (hPDL-MSCs) exhibit a tight bi-directional interaction with CD4(+) T lymphocytes. The hPDL-MSCs’ immunomodulatory abilities are drastically enhanced by pro-inflammatory cytokines via boosting the expression of various immunomediators. 25-hydroxyvitamin D(3) (25(OH)D(3)), the major metabolite of vitamin D3 in the blood, affects both hPDL-MSCs and CD4(+) T lymphocytes, but its influence on their interaction is unknown. METHODS: Therefore, primary hPDL-MSCs were stimulated in vitro with tumor necrosis factor (TNF)-α a or interleukin (IL)-1β in the absence and presence of 25(OH)D(3) followed by an indirect co-culture with phytohemagglutinin-activated CD4(+) T lymphocytes. The CD4(+) T lymphocyte proliferation, viability, and cytokine secretion were analyzed. Additionally, the expression of various immunomediators in hPDL-MSCs was investigated, and their implication was verified by using pharmacological inhibitors. RESULTS: 25(OH)D(3) significantly counteracted the suppressive effects of IL-1β-treated hPDL-MSCs on CD4(+) T lymphocyte proliferation, whereas no effects were observed in the presence of TNF-α. Additionally, 25(OH)D(3) significantly increased the percentage of viable CD4(+) T lymphocytes via TNF-α- or IL-1β-treated hPDL-MSCs. It also caused a significant decrease in interferon-γ, IL-17A, and transforming growth factor-β productions, which were triggered by TNF-α-treated hPDL-MSCs. 25(OH)D(3) significantly decreased the production of various immunomediators in hPDL-MSCs. Inhibition of two of them, prostaglandin E2 and indoleamine-2,3-dioxygenase-1, partially abolished some of the hPDL-MSCs-mediated effects of 25(OH)D(3) on CD4(+) T lymphocytes. CONCLUSION: These data indicate that 25(OH)D(3) influences the immunomodulatory activities of hPDL-MSCs. This modulatory potential seems to have high plasticity depending on the local cytokine conditions and may be involved in regulating periodontal tissue inflammatory processes. |
---|